← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2010Last known activity
Oct 1, 2025
Timeline
1990s
- Jan 1, 1998
Multiple Myeloma Research Consortium— Founded
Drugs by trial phase (30 distinct, 18 trials)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT07053436Lead sponsorPhase 2Oct 1, 2025
- NCT06171685Lead sponsorPhase 2Jul 31, 2024
- NCT06107738CollaboratorPhase 2Jan 16, 2024
- NCT05560399CollaboratorEarly Phase 1Oct 15, 2022
- NCT04150965Lead sponsorPhase 1/Phase 2Dec 1, 2019
- NCT03732703Lead sponsorPhase 1/Phase 2Apr 1, 2019
- NCT03773107CollaboratorPhase 1/Phase 2Jan 3, 2019
- NCT03252600CollaboratorPhase 2Aug 25, 2017
- NCT03091257CollaboratorPhase 1May 1, 2017
- NCT02903381CollaboratorPhase 2Oct 1, 2016
- NCT02765854CollaboratorPhase 2Sep 1, 2016
- NCT02718833CollaboratorPhase 2Jun 1, 2016
- NCT01672736CollaboratorPhase 1/Phase 2Sep 1, 2012
- NCT01562405CollaboratorPhase 1May 1, 2012
- NCT01497093CollaboratorPhase 1Feb 15, 2012
Details
- Founded
- Norwalk, CT, US Jan 1, 1998
- Last known activity
- Oct 1, 2025